enrasentan has been researched along with Chronic Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Engelberts, D; Jankov, RP; Kantores, C; Kavanagh, BP; McNamara, PJ; Murthy, P; Teixeira, L | 1 |
| Bochnowicz, S; Hart, TK; Hay, DW; Louden, CS; Ohlstein, EH; Osborn, RR; Underwood, DC | 1 |
| Abraham, WT; Lamba, S; Suresh, DP | 1 |
1 review(s) available for enrasentan and Chronic Disease
| Article | Year |
|---|---|
New developments in heart failure: role of endothelin and the use of endothelin receptor antagonists.
Topics: Bosentan; Carboxylic Acids; Chronic Disease; Endothelin Receptor Antagonists; Endothelin-1; Heart Failure; Humans; Indans; Peptides, Cyclic; Prognosis; Pyridines; Pyrimidines; Receptors, Endothelin; Sulfonamides; Treatment Outcome | 2000 |
2 other study(ies) available for enrasentan and Chronic Disease
| Article | Year |
|---|---|
Therapeutic hypercapnia prevents chronic hypoxia-induced pulmonary hypertension in the newborn rat.
Topics: Animals; Animals, Newborn; Body Weight; Carbon Dioxide; Carboxylic Acids; Chronic Disease; Endothelin Receptor Antagonists; Endothelin-1; Female; Hematocrit; Hypercapnia; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Indans; Oxidative Stress; Oxygen; Pregnancy; Pulmonary Artery; Pulmonary Circulation; Rats; Up-Regulation | 2006 |
Chronic hypoxia-induced cardiopulmonary changes in three rat strains: inhibition by the endothelin receptor antagonist SB 217242.
Topics: Animals; Blood Pressure; Carboxylic Acids; Chronic Disease; Endothelin Receptor Antagonists; Hypoxia; Indans; Lung; Male; Myocardium; Pulmonary Artery; Rats; Rats, Inbred Strains; Rats, Sprague-Dawley; Time Factors | 1998 |